Update SRA to SRiA 26 February 2018 Laura Piddock Linda van Gaalen

Scientific Advisory Board Meetings 2017 20 February - Brussels 20 June 2017 – Amsterdam 13-14 December 2017 - Amsterdam Work Input on SRA update Input for call topics Review of SRA pillars

Scientific review of the SRA pillars SAB Subgroups Therapeutics D. Transmission Diagnostics F. Environment Surveillance E. Interventions Result Consolidated scientific review per pillar Next The SAB will review the SRiA updated text in May 2018 Dependent upon the scientific requirements of the SC and MB, the SAB may meet again autumn 2018

Milestone 17: Editorial board – December 2017 Working group 5.1 becomes Editorial Board: Linda van Gaalen (WG leader) Antoine Andremont (France) Jessica Boname (United Kingdom) Martijntje Bakker (Netherlands) Virginie Mouchel (France) Patriq Fagerstedt (Sweden) Maria Josefina Ruiz Alvarez (Italy) Gian Maria Rossolini (Italy) Kay Duggan-Walls (Ireland) Laura Plant (Support) Martine Batoux (France) Marita van de Laar (Support) Monthly teleconferences: 27 Oct., 23 Nov., 18 Dec., 18 Jan. Meeting 2 February 2018 – Brussels Monthly teleconferences in 2018

Editorial Board meeting - 2 February 2018 Chair Editorial Board Antoine Andremont has agreed to be chair of the EB. Expand Editorial Board Turkey has requested to be present in this meeting and will be happy to join in the EB. Could the EB approach India, South Africa and Finland to take a seat in the EB? Any other middle income countries?

Editorial Board meeting - 2 February 2018 EB worked on revision of the table of Topics – Focus – Research activities of the SRA with input from SAB review documents. EB members are rewriting the SRA-text according to SAB review. France: Diagnostics Netherlands: Surveillance Sweden: Interventions Italy: Therapeutics UK: Overarching issues Turkey: Environment Ireland: Transmission SAB will be consulted end of April 2018 to review the draft SRiA.

Suggestions for the MB to decide To conduct an open consultation. Specifically ask patient groups, hospitals, primary care representatives etc. August – September 2018 Prepare a leaflet to be spread in international meetings to pre- announce the electronic consultation of the SRiA. Expression of interest.

Prioritization roadmap / implementation plan per pillar Working on the format Prepare a questionnaire to submit ideas for the roadmap. Open questionnaire? Approach: Members of JPIAMR Stakeholders Experts Support of MB?

Roadmap / innovation and implementation plan

Roadmap / innovation and implementation plan https://ec.europa.eu/health/sites/health/files/antimicrobial_resista nce/docs/roadmap_amr_en.pdf Action [description of action]   Objectives Research activities Policy activities Milestones [what are the objectives] [What research activities fit best] [What policy activities fit best] [What are measurable milestones] Documents supporting this action: [please list supporting documents and links to these documents, and place the documents on Google drive]

Review SRA timeline When What 26 february 2018 EB reporting to MB on progress SRA update. •Presenting ideas on roadmap •Discussion on some issues. 15-apr-18 Deadline EB for working on SRA text. •Share it with SAB for review. 28 May 2018 Deadline SAB for review on draft SRiA June- July 2018 EB working on draft SRiA •EB working on Roadmap questionnaire Summer 2018 Open consultation stakeholders on draft SRiA – in relation to their plans and actions (?) October 2018 Feedback from MB / JPIAMR member countries on draft SRiA •EB working on roadmap December 2018 SRiA submission to MB for approval (Digital) •Input for roadmap from JPIAMR member countries (?) Early 2019 •Roadmap workshop / consultation / conference (?)

Discussion @: jpiamr@zonmw.nl

Roadmaps by SRA pillars Outline for SRA update Update of text Innovation, LMIC, Scientific Update Roadmaps by SRA pillars Research & Innovation priorities and Implementation plan for JPIAMR SAB review (Dec) SAB input (Dec 17) 2017 2018 2017 2018 EB meeting (Feb) Template completed (Feb) Draft 1 (April) Consultation (Mar) -SAB -MB members -Scientific community and stakeholders (open online consultation) SAB 2nd review (May) MB review (June) Comments due 30 June 18 Draft 1 (Jun) -MB review (Jul/Aug) EB revision (July/Aug) Consultation key stakeholders (Sept) Stakeholder consultation (if needed) Draft 2 (Jun) -MB -SAB Final draft (Sept) Final draft (Nov) Editing and compilation: Final (Dec) MB final approval and adoption (Dec)